{"id":"W2967873913","doi":"10.1016/j.jpba.2019.112802","title":"Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Chemistry; Biosimilar; Bevacizumab; Chromatography; Dilution","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006423805,0.0001573254,0.0009640921,0.0004965178,0.00003397939,0.000009336151,0.0001600476,0.0002333895,0.0007588596],"category_scores_gemma":[0.00005046935,0.0001035914,0.0001916091,0.00125373,0.0005684902,0.00009342838,0.00004833831,0.0004571367,0.000002161807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003335762,"about_ca_system_score_gemma":0.0001136016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002464927,"about_ca_topic_score_gemma":0.00001928471,"domain_scores_codex":[0.9980621,0.0002477873,0.001026739,0.0002136527,0.0001875314,0.0002621373],"domain_scores_gemma":[0.9990392,0.0001497902,0.0004574555,0.0001160504,0.0001322149,0.0001053158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000635135,0.001262189,0.1218962,0.0000739805,0.0007549339,0.00001326524,0.00008981542,0.000001243945,0.8739414,0.0002905896,0.00002002008,0.001021215],"study_design_scores_gemma":[0.007589707,0.002780305,0.09554979,0.0004053614,0.002817857,0.00007161692,0.0003366008,0.001955142,0.88098,0.0001926492,0.006941738,0.0003792537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974349,0.0003366897,0.0004178585,0.001536648,0.00007786748,0.0001056589,0.00005443522,0.000003234649,0.00003272077],"genre_scores_gemma":[0.9994732,0.0001357275,0.0001457477,0.00007993721,0.00003063437,0.000001384018,0.00008945322,0.000004942747,0.0000390204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02634637,"threshold_uncertainty_score":0.830898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02673011554847484,"score_gpt":0.3792997637106538,"score_spread":0.352569648162179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}